Navigation Links
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
Date:11/13/2007

nt the equivalent of a therapeutic cure for patients suffering from this disease.

"Our vision is that one day all patients with hemophilia, regardless of where they live, will have access to treatment. More affordable treatment is critical to achieving treatment for all," stated Mark Skinner, President, World Federation of Hemophilia. "The availability of lower-cost rFIX products to treat hemophilia B could facilitate more prophylactic use, as well as make treatment more accessible to people worldwide."

About Hemophilia

Hemophilia is a lifelong, inherited bleeding disorder caused by low levels, or absence of a protein called a clotting factor, essential for blood clotting. This inability to clot results from an error in a person's genetic code, and occurs in approximately 1 in 10,000 male births. It is estimated that over 400,000 people worldwide suffer from hemophilia, of which only 25% currently receive therapy. There are two types of hemophilia, hemophilia A and hemophilia B. Hemophilia A is caused by a lack of Factor VIII and hemophilia B is caused by a deficiency of Factor IX.

About Recombinant Protein Manufacturing Technology

Inspiration Biopharmaceuticals uses novel patent protected, recombinant protein manufacturing technologies, which significantly increase cell-line productivity. This in turn decreases manufacturing capacity requirements, and significantly lowers the overall production cost for Factor products compared with existing manufacturing processes. Inspiration believes that its technologies will allow introduction of patient friendly, cost-effective products, which will provide equal or enhanced potency compared to those currently available.

About Inspiration Biopharmaceuticals

Inspiration Biopharmaceuticals, founded in 2004, is developing treatments for hemophilia that have the potential to broaden patient access to therapy, including prophylactic use. Greater access and more frequent, prophylactic therap
'/>"/>

SOURCE Inspiration Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...20 Milk. It does a body good. And,...ught. After years of,research, scientists at Onco...ow,s milk that stimulate the body,s own production...dia News Release, go to:, http://www.prnewswire.co...oping new cancer therapies, the chief scientist, D...
(Date:11/20/2008)...0 Radius Health ("Radius") announc...ion to its second institutional financing round, i...on and the total amount raised since the company,s...tional investors participated in the financing, le...PM Capital, The Wellcome Trust, HealthCare Venture...
(Date:11/20/2008)...mber 20 The Scandinavian-based dru...ed results of studies on its,lead antimicrobial c..., DC,the studies showed that the novel lytic pep...ct, significantly better towards killing Staphyloc...eted gold standard drugs. In,addition to this it ...
(Date:11/19/2008)...t achieve statistical significance , , ISEL...os Corporation (Nasdaq: PARS ) today announced r...ical NanoEmulsion (NE) drug delivery technology fo..., The multi-center, randomized, double-blinded,... efficacy of the Company,s 3% Diclofenac Diethanol...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2UT Southwestern surgeons complete first single incision lap band surgery in Texas 21775 1UT Southwestern surgeons complete first single incision lap band surgery in Texas 21775 2Asbestos Tragedy and Hope 21773 1Asbestos Tragedy and Hope 21773 2Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals 21768 1Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals 21768 2Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals 21768 3Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals 21768 4Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals 21768 5Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals 21768 6Moderate Aerobics May Ease Insomnia Symptoms 21763 1
...r 11, 2007 - Gloucester,Pharmaceuticals, Inc., an ...ced today that several abstracts covering,preclini...2007,Annual Meeting of the American Association of...pril 14-18, 2007. These,presentations will focus o...ultiple academic collaborators of the Company. Ful...
...-Apr 10, 2007 - Valeant,Pharmaceuticals Internatio...Phase 2 data for retigabine, a first-in-class,neur...ding,independent, scientific journal. The authors ...emonstrated reduction in monthly,seizure rates in ...nd RESTORE2) are currently underway to further inv...
Other Medicine Technology:Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 2Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 3Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 2Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 3
(Date:11/21/2008)...tCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ...ngly approved the proposals submitted to them rela...icals Industries Ltd. (Nasdaq: TEVA ). , ,...port of the transaction by the Barr shareholders,"...e are pleased with the progress that we continue t...
(Date:11/21/2008)... the second year in a row and the third time in th... agency network won more creative awards than any ...nal RX Club Show. , , Nine McCann Healthca...lub Awards of Excellence, including a Gold and 4 S...gencies include Caudex Medical, echo Torre Lazur, ...
(Date:11/21/2008)... of Texas M. D. Anderson Cancer Center marked the ...reast cancer in Panama through the Partnership for...cas today at an event with Laura Bush, the First L...orrijos, the First Lady of Panama. , Joining M...tment of State and Susan G. Komen for the Cure who...
(Date:11/21/2008)...a recent announcement, Governor,Schwarzenegger re...ude,"luxury" items such as veterinary services, w...er overpopulation. Animal welfare advocates acros... owners to take action and contact the,governor a...ur companion animals are family members and taking...
Breaking Medicine News(10 mins):Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3
...vironmental issue no one's talking about," regrets... activist and founder of the Work Less Party, a Va...our work week. "As a society, we're working expo...ty and it's making us miserable -- just look at ho...
... it doesnt have to be that way always. For experts...at they have successfully managed to reduce wrinkl...m containing vitamin A. Not only did the cream ma... samples from 23 people revealed it boosted levels...
...o has emerged a heartening development.The World H...in IM injection manufactured by the US based Insti...for inclusion in its Model List for Essential Medi... a cost-effective treatment for visceral leishmani...
... not to talk about, yet sufferers will go to extre...'s called overactive bladder (OAB) and it's chara...te, sometimes causing urine leakage. Now, to redu...awford Long Hospital urologist is using nerve stim...
Other Medicine News:Health News:Work Less to Sustain Planet Earth, Say Activists 2Health News:Work Less to Sustain Planet Earth, Say Activists 3Health News:Wrinkles can Be Really Ironed Out, Thanks to Vitamin A 2Health News:A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List 2Health News:A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List 3Health News:Stimulating the Ankle Can Help Patients With Overactive Bladder 2
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...The Ulti-Mist™ HME product line has the righ...to adults and from intubated patients to patients ...humidification for both anesthesia and critical ca...ers provide maximum protection for patients and st...
...These hygroscopic condenser humidifiers (HCH) capt...turn them in the inspired gas. Small and compact, ...ic and hygroscopic benefits. Depending on the tida...small-volume model., ,The adult HCH is ideal for ...
...These hygroscopic condenser humidifiers (HCH) capt...turn them in the inspired gas. Small and compact, ...ic and hygroscopic benefits. Depending on the tida...small-volume model., ,The adult HCH is ideal for ...
Medicine Products: